Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EBT: 2019-2024

Historic EBT for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' EBT rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • Per IDEAYA Biosciences' latest filing, its EBT stood at -$327.0 million for FY2024, which was down 143.23% from -$134.4 million recorded in FY2023.
  • IDEAYA Biosciences' 5-year EBT high stood at -$35.3 million for FY2020, and its period low was -$327.0 million during FY2024.
  • In the last 3 years, IDEAYA Biosciences' EBT had a median value of -$134.4 million in 2023 and averaged -$174.6 million.
  • Per our database at Business Quant, IDEAYA Biosciences' EBT increased by 20.16% in 2020 and then plummeted by 143.23% in 2024.
  • IDEAYA Biosciences' EBT (Yearly) stood at -$35.3 million in 2020, then crashed by 42.22% to -$50.3 million in 2021, then decreased by 24.34% to -$62.5 million in 2022, then tumbled by 115.08% to -$134.4 million in 2023, then crashed by 143.23% to -$327.0 million in 2024.